A mong patients with heart failure, neurohormonal blockade with angiotensin-converting enzyme inhibitors, β-adrenergic receptor blockers (BB), and aldosterone antagonists has been shown to improve mortality and hospitalization rates. 1-4 Combination therapy with these drugs can reduce mortality more than monotherapy alone. 5 Dosing is also important. Improvement in left ventricular function and survival are dosedependent effects for BB. 6 Most heart failure trials used relatively high doses of BB 7 and angiotensin-converting enzyme inhibitors. 8 Studies have found that many patients with heart failure are treated with dosages of BB and angiotensin-converting enzyme inhibitors below those used in clinical trials. 9 Unfortunately, all of these drug classes can cause hypotension. In our clinic, we regularly encounter patients with heart failure who have low normal blood pressure. We try to administer ≥2 classes of drugs, usually BB and angiotensinconverting enzyme inhibitors. Some patients, however, can only tolerate a single drug.
